Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Ditsch · SciRah

Researcher profile · Semantic Scholar

N. Ditsch

Share profile

N. Ditsch — researcher profile on SciRah

h-index: 47
Works: 345
Citations: 13K

Most-cited papers

Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
G. Montagna, M. Mrdutt, Susie X. Sun, C. Hlavin +54 more
2024JAMA Oncology105 citations Open access
Semantic Scholar
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)
M. Banys-Paluchowski, T. Kühn, Y. Masannat, I. Rubio +24 more
2023Cancers72 citations Open access
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025
T. Park-Simon, V. Müller, Ute-Susann Albert, M. Banys-Paluchowski +46 more
2025Breast Care27 citations Open access
Semantic Scholar
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Toralf Reimer, Thorsten Kühn, V. Müller, N. Ditsch +46 more
2025European Journal of Surgical Oncology19 citations Open access
Semantic Scholar
St. Gallen/Vienna 2025 Summary of Key Messages on Therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference
N. Ditsch, M. Gnant, C. Thomssen, Nadia Harbeck
2025Breast Care18 citations Open access
Semantic Scholar
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.
R. di Micco, Steffi Hartmann, M. Banys-Paluchowski, J. de Boniface +26 more
2025European Journal of Cancer18 citations
Semantic Scholar
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)
N. Krawczyk, Thorsten Kühn, N. Ditsch, Steffi Hartmann +13 more
2024Cancers18 citations
Semantic Scholar
Abstract GS4-02: Oncological Outcomes Following Omission of Axillary Lymph Node Dissection in Node Positive Patients Downstaging To Node Negative with Neoadjuvant Chemotherapy: the OPBC-04/EUBREAST-06/OMA study
G. Montagna, M. Mrdutt, Astrid Botty, A. Barrio +43 more
2023Cancer Research18 citations
Semantic Scholar
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024
T. Park-Simon, V. Müller, Ute-Susann Albert, M. Banys-Paluchowski +43 more
2024Breast Care14 citations Open access
Semantic Scholar
Treatment of Patients with Early Breast Cancer
M. Untch, M. Banys-Paluchowski, Sara Y. Brucker, C. Denkert +13 more
2025Geburtshilfe und Frauenheilkunde12 citations Open access
Semantic Scholar
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024
M. Thill, W. Janni, Ute-Susann Albert, M. Banys-Paluchowski +43 more
2024Breast Care12 citations Open access
Semantic Scholar
Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
Melitta Köpke, B. Aktas, N. Ditsch
2023Current Opinion in Obstetrics and Gynecology10 citations
Semantic Scholar
The Role of [18F]FES PET/CT in Breast Cancer Management: An Umbrella Review
M. Cuzzocrea, R. di Micco, G. E. Colombo, S. Rizzo +11 more
2025Cancers9 citations Open access
Semantic Scholar
Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer
R. Würstlein, H. Kolberg, A. Hartkopf, T. Fehm +26 more
2024Geburtshilfe und Frauenheilkunde9 citations Open access
Semantic Scholar
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery
N. Pochert, Mariella Schneider, M. Köpke, M. Wild +14 more
2023Archives of Gynecology and Obstetrics9 citations Open access
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025
M. Thill, W. Janni, Ute-Susann Albert, M. Banys-Paluchowski +46 more
2025Breast Care8 citations Open access
Semantic Scholar
The expression of TIM-3 and Gal-9 on macrophages and Hofbauer cells in the placenta of preeclampsia patients.
J. Mittelberger, M. Seefried, S. Löb, C. Kuhn +5 more
2024Journal of Reproductive Immunology8 citations Open access
Semantic Scholar
Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer
M. Lux, A. Hartkopf, T. Fehm, M. Welslau +26 more
2023Geburtshilfe und Frauenheilkunde8 citations Open access
Semantic Scholar
Treatment of Early Breast Cancer
M. Untch, M. Banys-Paluchowski, S. Brucker, W. Budach +18 more
2023Geburtshilfe und Frauenheilkunde8 citations Open access
Semantic Scholar
Abstract GS02-02: Are nodal ITCs after neoadjuvant chemotherapy an indication for axillary dissection? The OPBC05/EUBREAST-14R/ICARO study
G. Montagna, A. Laws, M. Ferrucci, M. Mrdutt +46 more
2024Cancer Research7 citations Open access
Semantic Scholar
Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer
W. Janni, H. Kolberg, A. Hartkopf, T. Fehm +27 more
2024Geburtshilfe und Frauenheilkunde7 citations Open access
Semantic Scholar
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).
Steffi Hartmann, M. Banys-Paluchowski, T. Berger, N. Ditsch +39 more
2025European Journal of Surgical Oncology6 citations Open access
Semantic Scholar
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.
Thorsten Kühn, M. Banys-Paluchowski, N. Ditsch, E. Stickeler +45 more
2025British Journal of Surgery6 citations
Semantic Scholar
Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer
D. Lüftner, H. Kolberg, A. Hartkopf, T. Fehm +27 more
2024Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
PD-L1 expression and characterization of its carrier macrophages in placentas with acute and specifically post-SARS-CoV-2 infection
M. Seefried, J. Mittelberger, M. Franitza, F. Garrido +8 more
2024Histochemistry and Cell Biology6 citations Open access
Semantic Scholar
Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
A. Hartkopf, T. Fehm, M. Welslau, V. Müller +26 more
2023Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk
V. Müller, Manuel Hörner, M. Thill, M. Banys-Paluchowski +31 more
2025Breast5 citations Open access
Semantic Scholar
Discussion of ABC7 Consensus and German Recommendations
M. Untch, N. Ditsch, P. Fasching, Steffi Busch +11 more
2024Geburtshilfe und Frauenheilkunde5 citations Open access
Semantic Scholar
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
Li-Li Lin, K. Pfender, N. Ditsch, C. Kuhn +9 more
2023Breast Cancer5 citations Open access
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026
M. Thill, V. Müller, T. Fehm, Ute-Susann Albert +43 more
2026Breast Care4 citations
Semantic Scholar
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
M. Banys-Paluchowski, Steffi Hartmann, T. Basali, M. Gasparri +42 more
2025Breast Cancer Research and Treatment4 citations
Semantic Scholar
ABC7 Consensus: Assessment by a German Group of Experts
N. Ditsch, M. Untch, P. Fasching, Steffi Busch +11 more
2024Breast Care4 citations Open access
Semantic Scholar
Abstract RF5-03: OlympiaN: a phase 2, multicenter, open-label study to assess the efficacy and safety of neoadjuvant olaparib monotherapy and olaparib plus durvalumab in patients with BRCA mutations and early-stage HER2-negative breast cancer
N. Tung, A. Stradella, A. Brufsky, P. Fasching +18 more
2026Clinical Cancer Research3 citations
Semantic Scholar
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective
D. Krug, M. Banys-Paluchowski, S. Brucker, C. Denkert +18 more
2024Strahlentherapie und Onkologie (Print)3 citations Open access
Semantic Scholar
COGNITION-GUIDE – Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study
C. Pixberg, Christian Maurer, K. Smetanay, Luise Strassl +32 more
2024Geburtshilfe und Frauenheilkunde3 citations Open access
Semantic Scholar
Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
Mariella Schneider, Michael Koepke, Alaleh Zati Zehni, T. Vilsmaier +7 more
2023Cancers3 citations Open access
Semantic Scholar
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial
Manuel Hörner, L. Tretschock, N. John, P. Ziegler +48 more
2026Breast Cancer Research and Treatment2 citations Open access
Semantic Scholar
ABC8 Consensus: Assessment by a German Group of Experts
N. Ditsch, M. Untch, P. Fasching, Susanne Briest +11 more
2026Breast Care2 citations
Semantic Scholar
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry
Manuel Hörner, A. Hartkopf, N. John, P. Ziegler +49 more
2026npj Breast Cancer2 citations Open access
Semantic Scholar
Preventive Measures for Patients With an Elevated Genetic Risk for Gynecological Malignancies, in Particular Familial Breast and Ovarian Cancer.
N. Ditsch, B. Aktas, M. Banys-Paluchowski, D. Speiser +2 more
2025Deutsches Ärzteblatt International2 citations
Semantic Scholar
Abstract PS6-06: Upstage of N-Stage by Diagnostic Axillary Lymph Node Dissection in Patients w/ Isolated Tumor Cells or Micrometastases in Sentinel/Target Lymph Node after Neoadjuvant Chemotherapy - Results from the Prospective Multicenter AXSANA / EUBREAST 3 Study
T. Kuehn, M. Banys-Paluchowski, N. Ditsch, E. Stickeler +42 more
2025Clinical Cancer Research2 citations
Semantic Scholar
Abstract RF4-02: Efficacy Analysis of the Randomized Phase III DETECT V trial: Treatment De-escalation by Omission of Chemotherapy and the Effect of Adding Ribociclib in HER2-positive and Hormone-receptor Positive Metastatic Breast Cancer
W. Janni, T. Fehm, V. Müller, J. Blohmer +15 more
2026Clinical Cancer Research1 citations
Semantic Scholar
Abstract GS2-01: More versus less invasive axillary surgical staging procedures in breast cancer patients converting from a clinically node-positive to a clinically node-negative stage through neoadjuvant chemotherapy - primary endpoint analysis of the international prospective multicenter AXSANA/EU
T. Kühn, M. Banys-Paluchowski, N. Ditsch, E. Stickeler +44 more
2026Clinical Cancer Research1 citations
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026
T. Park-Simon, V. Müller, Ute-Susann Albert, M. Banys-Paluchowski +43 more
2026Breast Care1 citations Open access
Semantic Scholar
AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 Update
Andreas D. Hartkopf, Ute-Susann Albert, R. Bartsch, I. Bauerfeind +43 more
2026Breast1 citations Open access
Semantic Scholar
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.
N. Herold, Christoph Engel, D. Speiser, T. Ripperger +34 more
2026European Journal of Cancer1 citations Open access
Semantic Scholar
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
L. Michel, P. Ziegler, Philipp Kreis, A. Hartkopf +30 more
2025European Journal of Cancer1 citations Open access
Semantic Scholar
A low nuclear-to-cytoplasmic ratio of VDR expression is an independent prognostic marker in breast cancer.
Charlotte Schubert, T. Vilsmaier, F. Batz, V. Cavaillès +10 more
2025Histology and Histopathology1 citations
Semantic Scholar
Significant Increase of Patient Information and Satisfaction with Longer Initial Consultation Duration in Breast Cancer - First Results of the WAVES Study
N. Ditsch, M. Köpke, R. Haidinger, Brigitte Welter
2025Fortune Journal of Health Sciences1 citations Open access
Semantic Scholar
Macrophage polarization is associated with postoperative seroma development in breast cancer in the SerMa pilot cohort
Felicitas Schneider, N. Pochert, F. Schittek, M. Köpke +18 more
2025Scientific Reports1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Banys-Paluchowski×33
Invite
M. Banys-Paluchowski — researcher profile on SciRah
D. Lüftner×21
Invite
D. Lüftner — researcher profile on SciRah
E. Stickeler×20
Invite
E. Stickeler — researcher profile on SciRah
T. Fehm×19
Invite
T. Fehm — researcher profile on SciRah

×18

Invite

V. Müller — researcher profile on SciRah

Invite

M. Lux — researcher profile on SciRah

Invite

M. Thill — researcher profile on SciRah

Invite

M. Untch — researcher profile on SciRah

Invite

H. Kolberg — researcher profile on SciRah

P. Fasching×15

Invite

P. Fasching — researcher profile on SciRah

A. Hartkopf×15

Invite

A. Hartkopf — researcher profile on SciRah

Invite

T. Kühn — researcher profile on SciRah